Susquehanna International Group
TEVA icon

Susquehanna International Group’s Teva Pharmaceuticals TEVA Stock Holding History

Susquehanna International Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$220M Buy
7,303,700
+826,200
+13% +$26.6M 0.02% 484
2025
Q4 		$202M Buy
6,477,500
+882,700
+16% +$21.7M 0.02% 534
2025
Q3 		$113M Buy
5,594,800
+1,744,400
+45% +$30.6M 0.01% 810
2025
Q2 		$64.5M Buy
3,850,400
+1,217,000
+46% +$19.6M 0.01% 998
2025
Q1 		$40.5M Sell
2,633,400
-2,839,600
-52% -$50.7M 0.01% 1159
2024
Q4 		$121M Buy
5,473,000
+3,226,700
+144% +$58.7M 0.02% 606
2024
Q3 		$40.5M Sell
2,246,300
-1,436,900
-39% -$25.1M 0.01% 1233
2024
Q2 		$59.9M Sell
3,683,200
-2,300
-0.1% -$35.4K 0.01% 868
2024
Q1 		$52M Sell
3,685,500
-533,900
-13% -$6.73M 0.01% 1010
2023
Q4 		$44.1M Sell
4,219,400
-568,200
-12% -$5.3M 0.01% 1119
2023
Q3 		$48.8M Buy
4,787,600
+3,290,800
+220% +$30.6M 0.01% 1022
2023
Q2 		$11.3M Sell
1,496,800
-784,900
-34% -$6.36M ﹤0.01% 2360
2023
Q1 		$20.2M Sell
2,281,700
-1,712,600
-43% -$16.9M ﹤0.01% 1698
2022
Q4 		$36.4M Buy
3,994,300
+434,700
+12% +$3.79M 0.01% 1076
2022
Q3 		$28.7M Sell
3,559,600
-1,987,900
-36% -$17.6M 0.01% 1137
2022
Q2 		$41.7M Sell
5,547,500
-1,046,100
-16% -$9.11M 0.01% 947
2022
Q1 		$61.9M Sell
6,593,600
-1,518,800
-19% -$12.7M 0.01% 891
2021
Q4 		$65M Sell
8,112,400
-3,031,900
-27% -$27.4M 0.01% 942
2021
Q3 		$109M Sell
11,144,300
-143,900
-1% -$1.35M 0.01% 747
2021
Q2 		$112M Buy
11,288,200
+1,702,800
+18% +$18M 0.02% 741
2021
Q1 		$111M Buy
9,585,400
+6,382,200
+199% +$73.2M 0.02% 677
2020
Q4 		$30.9M Sell
3,203,200
-983,900
-23% -$9.43M 0.01% 1347
2020
Q3 		$37.7M Sell
4,187,100
-3,487,800
-45% -$36.9M 0.01% 1029
2020
Q2 		$94.6M Sell
7,674,900
-2,146,400
-22% -$24.3M 0.02% 524
2020
Q1 		$88.2M Buy
9,821,300
+2,165,300
+28% +$22.2M 0.03% 434
2019
Q4 		$75M Buy
7,656,000
+2,119,400
+38% +$18.9M 0.02% 607
2019
Q3 		$38.1M Buy
5,536,600
+1,865,600
+51% +$14.3M 0.01% 899
2019
Q2 		$33.9M Sell
3,671,000
-10,700
-0.3% -$129K 0.01% 922
2019
Q1 		$57.7M Sell
3,681,700
-8,482,000
-70% -$150M 0.02% 554
2018
Q4 		$188M Buy
12,163,700
+1,853,400
+18% +$38M 0.07% 229
2018
Q3 		$222M Buy
10,310,300
+1,667,800
+19% +$38.7M 0.07% 226
2018
Q2 		$210M Buy
8,642,500
+1,136,000
+15% +$23.2M 0.07% 235
2018
Q1 		$128M Sell
7,506,500
-517,700
-6% -$10.1M 0.05% 316
2017
Q4 		$152M Buy
8,024,200
+4,879,200
+155% +$73.4M 0.05% 301
2017
Q3 		$55.4M Sell
3,145,000
-314,700
-9% -$7.08M 0.02% 593
2017
Q2 		$115M Buy
3,459,700
+1,969,500
+132% +$61M 0.05% 311
2017
Q1 		$47.8M Sell
1,490,200
-808,000
-35% -$27.6M 0.02% 594
2016
Q4 		$83.3M Buy
2,298,200
+762,900
+50% +$30.5M 0.04% 381
2016
Q3 		$70.6M Buy
1,535,300
+211,100
+16% +$11M 0.03% 412
2016
Q2 		$66.5M Sell
1,324,200
-993,900
-43% -$52.9M 0.04% 417
2016
Q1 		$124M Sell
2,318,100
-744,300
-24% -$43.7M 0.07% 252
2015
Q4 		$201M Buy
3,062,400
+479,300
+19% +$29.6M 0.09% 185
2015
Q3 		$146M Buy
2,583,100
+768,700
+42% +$49.8M 0.06% 266
2015
Q2 		$107M Sell
1,814,400
-1,424,300
-44% -$87.9M 0.05% 373
2015
Q1 		$202M Buy
3,238,700
+1,288,800
+66% +$74.9M 0.09% 197
2014
Q4 		$112M Sell
1,949,900
-22,200
-1% -$1.24M 0.04% 371
2014
Q3 		$106M Sell
1,972,100
-854,700
-30% -$45.3M 0.04% 385
2014
Q2 		$148M Sell
2,826,800
-935,200
-25% -$47.8M 0.06% 264
2014
Q1 		$199M Buy
3,762,000
+1,102,400
+41% +$51M 0.09% 183
2013
Q4 		$107M Buy
2,659,600
+1,821,700
+217% +$71.7M 0.05% 321
2013
Q3 		$31.7M Buy
837,900
+56,500
+7% +$2.2M 0.02% 873
2013
Q2 		$30.6M Buy
+781,400
New +$30.4M 0.02% 812

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group's TEVA Position: Q1 2026 in Review

Susquehanna International Group increased its Teva Pharmaceuticals (TEVA) stake by 877% in Q1 2026, buying an estimated $21.4M and bringing the position to 739,515 shares worth $22.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2091.

Susquehanna International Group first reported a position in TEVA in Q2 2013 and has held it in 49 quarters since. The position peaked at $154M in Q3 2016. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Susquehanna International Group held 739,515 shares of Teva Pharmaceuticals worth $22.3M as of Q1 2026.
  • Susquehanna International Group bought 663,802 Teva Pharmaceuticals shares in Q1 2026, an estimated $21.4M.
  • Teva Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2091 holding.
  • Susquehanna International Group first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
  • Susquehanna International Group's Teva Pharmaceuticals position peaked at $154M in Q3 2016.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.